ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics
The collaboration seeks to produce novel off-the-shelf TCR-based bispecific molecules designed to overcome current limitations in cell therapy approaches against solid tumors
EnCharge AI Welcomes Former Qualcomm Executive Don Rosenberg to its Board of Directors and Jonny Morris to Executive Team
EnCharge AI’s team expansion comes on the heels of its oversubscribed funding round, bringing total funding to $45M to support its full-stack AI chipset.
ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development
MiNK Therapeutics combines its unique, proprietary library of T-cell antigens with ImmunoScape’s cutting-edge platform for rapid discovery of novel T-cell receptors
NUBURU Expands Automotive Manufacturing Offering with Wire Welding Solutions, Enabling High Yield Needed for Mass Production
Secures Purchase Order for BlueScan Solution from a Worldwide Leader in Coils and Motors Production, Replacing Traditional Arc Welding with Next-Gen Blue Laser Wire Welding
ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scientific Advisory Board
Expertise from award-winning computational biologist, human immunologist and engineer with experience from Yale, NIH, and NIAID will help advance ImmunoScape’s machine learning capabilities
Zeteo Tech Awarded $1.87M DHS Science & Technology Directorate Contract to Develop and Test the Next Generation of the digitalMALDI® Real-Time Biological Threat Detection Technology
Zeteo Tech, Inc. announced today that it has been awarded a Phase III Small Business Innovation Research contract for $1.87M with a potential value of up to $5.86 million (including options) from the U.S. Department of Homeland Security (DHS).
CytoTronics’ Breakthrough Semiconductor Platform Poised to Set New Standard in High-Throughput Phenotypic Screening for Drug Discovery
Published data showcases the company’s potential to revolutionize pharmaceutical research
South 8 Debuts its Arctic™ LiGas® Battery Electrolyte for Reliable, Safe Performance in Extreme Environments
South 8’s new 18650 battery cell uses the company’s liquefied gas electrolyte to minimize fire risk while delivering world-record cold weather performance
TeraPore Launches IsoBlock® VF Viral Filtration Product Line with Proprietary Membrane Technology that Delivers Consistent Results
TeraPore Technologies has commercially launched the flagship IsoBlock® VF product line for parvovirus removal from biopharmaceuticals.
EnCharge AI Closes Additional $22.6M from VentureTech Alliance, RTX Ventures and ACVC Partners to Unlock AI Compute
TeraPore Technologies has commercially launched the flagship IsoBlock® VF product line for parvovirus removal from biopharmaceuticals.